Exploring the potential role of tungsten carbide cobalt (WC-Co) nanoparticle internalization in observed toxicity toward lung epithelial cells in vitro

Toxicology and Applied Pharmacology

Volumn 278, Issue 1, 2014, Pages 1-8

  Armstead, Andrea L ^a,b   Arena, Christopher B ^a   Li, Bingyun ^a,b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Hard metal; Internalization; Lung disease; Nanoparticle; Nanotoxicity; Pulmonary exposure

Indexed keywords

CARBON; COBALT; METAL COMPLEX; NANOPARTICLE; OXYGEN; TUNGSTEN; TUNGSTEN CARBIDE COBALT; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; CYTOTOXICITY; INTERNALIZATION; LUNG ALVEOLUS EPITHELIUM; MICROTUBULE; OXIDATIVE STRESS; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY;

HARD METAL; INTERNALIZATION; LUNG DISEASE; NANOPARTICLE; NANOTOXICITY; PULMONARY EXPOSURE;

APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; COBALT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCYTOSIS; EPITHELIAL CELLS; HUMANS; INHALATION EXPOSURE; LUNG; METAL NANOPARTICLES; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PARTICLE SIZE; TIME FACTORS; TUNGSTEN COMPOUNDS;

EID: 84899795392     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2014.04.008     Document Type: Article

References (84)

1. Adamis Z., Tatrai E., Honma K., Karpati J., Ungvary G. A study on lung toxicity of respirable hard metal dusts in rats. Ann. Occup. Hyg. 1997, 41:515-526.
2. Anard D., Kirsch-Volders M., Elhajouji A., Belpaeme K., Lison D. In vitro genotoxic effects of hard metal particles assessed by alkaline single cell gel and elution assays. Carcinogenesis 1997, 18:177-184.
3. Antonini J.M., Starks K., Roberts J.R., Millecchia L., Yang H.M., Rao K.M. Changes in F-actin organization induced by hard metal particle exposure in rat pulmonary epithelial cells using laser scanning confocal microscopy. In Vitro Mol. Toxicol. 2000, 13:5-16.
4. Armstead A.L., Li B. Nanomedicine as an emerging approach against intracellular pathogens. Int. J. Nanomedicine 2011, 6:3281-3293.
5. Balmes J.R. Respiratory effects of hard-metal dust exposure. Occup. Med. 1987, 2:327-344.
6. Bastian S., Busch W., Kuhnel D., Springer A., Meissner T., Holke R., Scholz S., Iwe M., Pompe W., Gelinsky M., Potthoff A., Richter V., Ikonomidou C., Schirmer K. Toxicity of tungsten carbide and cobalt-doped tungsten carbide nanoparticles in mammalian cells in vitro. Environ. Health Perspect. 2009, 117:530-536.
7. Bech A.O., Kipling M.D., Heather J.C. Hard metal disease. Br. J. Ind. Med. 1962, 19:239-252.
8. Beritic T., Prpic Majic D., Mark B., Markicevic A., Vurdelja B. Pheumoconiosis Caused by Hard Metal Dust. Arh. Hig. Rada Toksikol. 1963, 14:261-268.
9. Busch W., Kuhnel D., Schirmer K., Scholz S. Tungsten carbide cobalt nanoparticles exert hypoxia-like effects on the gene expression level in human keratinocytes. BMC Genomics 2010, 11:65.
10. Canton I., Battaglia G. Endocytosis at the nanoscale. Chem. Soc. Rev. 2012, 41:2718-2739.
11. Champion J.A., Mitragotri S. Role of target geometry in phagocytosis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:4930-4934.
12. Chiappino G. Hard metal disease: clinical aspects. Sci. Total Environ. 1994, 150:65-68.
13. Cooper J.A. Effects of cytochalasin and phalloidin on actin. J. Cell Biol. 1987, 105:1473-1478.
14. Cugell D.W. The hard metal diseases. Clin. Chest Med. 1992, 13:269-279.
15. Day G.A., Virji M.A., Stefaniak A.B. Characterization of exposures among cemented tungsten carbide workers. Part II: Assessment of surface contamination and skin exposures to cobalt, chromium and nickel. J. Expo. Sci. Environ. Epidemiol. 2009, 19:423-434.
16. De Boeck M., Hoet P., Lombaert N., Nemery B., Kirsch-Volders M., Lison D. In vivo genotoxicity of hard metal dust: induction of micronuclei in rat type II epithelial lung cells. Carcinogenesis 2003, 24:1793-1800.
17. De Boeck M., Lombaert N., De Backer S., Finsy R., Lison D., Kirsch-Volders M. In vitro genotoxic effects of different combinations of cobalt and metallic carbide particles. Mutagenesis 2003, 18:177-186.
18. Ding M., Kisin E.R., Zhao J., Bowman L., Lu Y., Jiang B., Leonard S., Vallyathan V., Castranova V., Murray A.R., Fadeel B., Shvedova A.A. Size-dependent effects of tungsten carbide-cobalt particles on oxygen radical production and activation of cell signaling pathways in murine epidermal cells. Toxicol. Appl. Pharmacol. 2009, 241:260-268.
19. dos Santos T., Varela J., Lynch I., Salvati A., Dawson K.A. Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One 2011, 6:e24438.
20. Dunlop P., Muller N.L., Wilson J., Flint J., Churg A. Hard metal lung disease: high resolution CT and histologic correlation of the initial findings and demonstration of interval improvement. J. Thorac. Imaging 2005, 20:301-304.
21. Edel J., Sabbioni E., Pietra R., Rossi A., Torre M., Rizzato G., Fraioli P. Trace metal lung disease: in vitro interaction of hard metals with human lung and plasma components. Sci. Total Environ. 1990, 95:107-117.
22. Elkjaer M.L., Birn H., Agre P., Christensen E.I., Nielsen S. Effects of microtubule disruption on endocytosis, membrane recycling and polarized distribution of Aquaporin-1 and gp330 in proximal tubule cells. Eur. J. Cell Biol. 1995, 67:57-72.
23. Fedan J.S., Cutler D. Hard metal-induced disease: effects of metal cations in vitro on guinea pig isolated airways. Toxicol. Appl. Pharmacol. 2001, 174:199-206.
24. Goddette D.W., Frieden C. Actin polymerization. The mechanism of action of cytochalasin D. J. Biol. Chem. 1986, 261:15974-15980.
25. Gotway M.B., Golden J.A., Warnock M., Koth L.L., Webb R., Reddy G.P., Balmes J.R. Hard metal interstitial lung disease: high-resolution computed tomography appearance. J. Thorac. Imaging 2002, 17:314-318.
26. Guadagnini R., Halamoda Kenzaoui B., Cartwright L., Pojana G., Magdolenova Z., Bilanicova D., Saunders M., Juillerat L., Marcomini A., Huk A., Dusinska M., Fjellsbo L.M., Marano F., Boland S. Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests. Nanotoxicology 2013, (Epub ahead of print, July 27, 2013). 10.3109/17435390.2013.829590.
27. Heuer W. Pulmonary fibrosis in hard metal-production workers. Int. Arch. Gewerbepathol. Gewerbehyg. 1962, 19:613-632.
28. Holdenrieder S., Stieber P. Circulating apoptotic markers in the management of non-small cell lung cancer. Cancer Biomark. 2010, 6:197-210.
29. Holder A.L., Goth-Goldstein R., Lucas D., Koshland C.P. Particle-induced artifacts in the MTT and LDH viability assays. Chem. Res. Toxicol. 2012, 25:1885-1892.
30. Huaux F., Lasfargues G., Lauwerys R., Lison D. Lung toxicity of hard metal particles and production of interleukin-1, tumor necrosis factor-alpha, fibronectin, and cystatin-c by lung phagocytes. Toxicol. Appl. Pharmacol. 1995, 132:53-62.
31. Joseph M. Hard metal pneumoconiosis. Australas. Radiol. 1968, 12:92-95.
32. Kerfoot E.J., Fredrick W.G., Domeier E. Cobalt metal inhalation studies on miniature swine. Am. Ind. Hyg. Assoc. J. 1975, 36:17-25.
33. Kitamura H., Yoshimura Y., Tozawa T., Koshi K. Effects of cemented tungsten carbide dust on rat lungs following intratracheal injection of saline suspension. Acta Pathol. Jpn. 1980, 30:241-253.
34. Kraus T., Schramel P., Schaller K.H., Zobelein P., Weber A., Angerer J. Exposure assessment in the hard metal manufacturing industry with special regard to tungsten and its compounds. Occup. Environ. Med. 2001, 58:631-634.
35. Kroll A., Pillukat M.H., Hahn D., Schnekenburger J. Interference of engineered nanoparticles with in vitro toxicity assays. Arch. Toxicol. 2012, 86:1123-1136.
36. Kuhnel D., Busch W., Meissner T., Springer A., Potthoff A., Richter V., Gelinsky M., Scholz S., Schirmer K. Agglomeration of tungsten carbide nanoparticles in exposure medium does not prevent uptake and toxicity toward a rainbow trout gill cell line. Aquat. Toxicol. 2009, 93:91-99.
37. Kuhnel D., Scheffler K., Wellner P., Meissner T., Potthoff A., Busch W., Springer A., Schirmer K. Comparative evaluation of particle properties, formation of reactive oxygen species and genotoxic potential of tungsten carbide based nanoparticles in vitro. J. Hazard. Mater. 2012, 227-228:418-426.
38. Kusaka Y., Kuwabara O., Kitamura H. A case of diffuse lung disease associated with lung cancer in a hard metal worker. Nihon Kyobu Shikkan Gakkai Zasshi 1984, 22:804-808.
39. Lasfargues G., Lison D., Maldague P., Lauwerys R. Comparative study of the acute lung toxicity of pure cobalt powder and cobalt-tungsten carbide mixture in rat. Toxicol. Appl. Pharmacol. 1992, 112:41-50.
40. Lasfargues G., Wild P., Moulin J.J., Hammon B., Rosmorduc B., Rondeau du Noyer C., Lavandier M., Moline J. Lung cancer mortality in a French cohort of hard-metal workers. Am. J. Ind. Med. 1994, 26:585-595.
41. Lasfargues G., Lardot C., Delos M., Lauwerys R., Lison D. The delayed lung responses to single and repeated intratracheal administration of pure cobalt and hard metal powder in the rat. Environ. Res. 1995, 69:108-121.
42. Li J., S M., Ng C., LY Y., BH B. Nanoparticle-induced pulmonary toxicity. Exp. Biol. Med. 2010, 235:1025-1033.
43. Lison D., Lauwerys R. In vitro cytotoxic effects of cobalt-containing dusts on mouse peritoneal and rat alveolar macrophages. Environ. Res. 1990, 52:187-198.
44. Lison D., Lauwerys R. Study of the mechanism responsible for the elective toxicity of tungsten carbide-cobalt powder toward macrophages. Toxicol. Lett. 1992, 60:203-210.
45. Lison D., Lauwerys R. Evaluation of the role of reactive oxygen species in the interactive toxicity of carbide-cobalt mixtures on macrophages in culture. Arch. Toxicol. 1993, 67:347-351.
46. Lison D., Carbonnelle P., Mollo L., Lauwerys R., Fubini B. Physicochemical mechanism of the interaction between cobalt metal and carbide particles to generate toxic activated oxygen species. Chem. Res. Toxicol. 1995, 8:600-606.
47. Lombaert N., De Boeck M., Decordier I., Cundari E., Lison D., Kirsch-Volders M. Evaluation of the apoptogenic potential of hard metal dust (WC-Co), tungsten carbide and metallic cobalt. Toxicol. Lett. 2004, 154:23-34.
48. Lombaert N., Lison D., Van Hummelen P., Kirsch-Volders M. In vitro expression of hard metal dust (WC-Co)-responsive genes in human peripheral blood mononucleated cells. Toxicol. Appl. Pharmacol. 2008, 227:299-312.
49. Lombaert N., Castrucci E., Decordier I., Van Hummelen P., Kirsch-Volders M., Cundari E., Lison D. Hard-metal (WC-Co) particles trigger a signaling cascade involving p38 MAPK, HIF-1alpha, HMOX1, and p53 activation in human PBMC. Arch. Toxicol. 2012, 87:259-268.
50. Luo H., Jiang B., Li B., Li Z., Jiang B.H., Chen Y.C. Kaempferol nanoparticles achieve strong and selective inhibition of ovarian cancer cell viability. Int. J. Nanomedicine 2012, 7:3951-3959.
51. Mariano A., Sartorelli P., Innocenti A. Evolution of hard metal pulmonary fibrosis in two artisan grinders of woodworking tools. Sci. Total Environ. 1994, 150:219-221.
52. Matejka M.H., Wernisch J., Lill W., Fuchsjager E., Watzek G. Heavy metal deposits in pathologically modified hard tissues. Clinical and experimental studies. Wien. Med. Wochenschr. 1985, 135:523-525.
53. Migliori M., Mosconi G., Michetti G., Belotti L., D'Adda F., Leghissa P., Musitelli O., Cassina G., Motta T., Seghizzi P., et al. Hard metal disease: eight workers with interstitial lung fibrosis due to cobalt exposure. Sci. Total Environ. 1994, 150:187-196.
54. Moriyama H., Kobayashi M., Takada T., Shimizu T., Terada M., Narita J., Maruyama M., Watanabe K., Suzuki E., Gejyo F. Two-dimensional analysis of elements and mononuclear cells in hard metal lung disease. Am. J. Respir. Crit. Care Med. 2007, 176:70-77.
55. Moulin J.J., Wild P., Romazini S., Lasfargues G., Peltier A., Bozec C., Deguerry P., Pellet F., Perdrix A. Lung cancer risk in hard-metal workers. Am. J. Epidemiol. 1998, 148:241-248.
56. Naqvi A.H., Hunt A., Burnett B.R., Abraham J.L. Pathologic spectrum and lung dust burden in giant cell interstitial pneumonia (hard metal disease/cobalt pneumonitis): review of 100 cases. Arch. Environ. Occup. Health 2008, 63:51-70.
57. Nemery B., Abraham J.L. Hard metal lung disease: still hard to understand. Am. J. Respir. Crit. Care Med. 2007, 176:2-3.
58. Nemery B., Verbeken E.K., Demedts M. Giant cell interstitial pneumonia (hard metal lung disease, cobalt lung). Semin. Respir. Crit. Care Med. 2001, 22:435-448.
59. Nunez J., Fellous A., Francon J., Lennon A.M. Competitive inhibition of colchicine binding to tubulin by microtubule-associated proteins. Proc. Natl. Acad. Sci. U. S. A. 1979, 76:86-90.
60. Nurkiewicz T.R., Porter D.W., Hubbs A.F., Stone S., Moseley A.M., Cumpston J.L., Goodwill A.G., Frisbee S.J., Perrotta P.L., Brock R.W., Frisbee J.C., Boegehold M.A., Frazer D.G., Chen B.T., Castranova V. Pulmonary particulate matter and systemic microvascular dysfunction. Res. Rep. Health Eff. Inst. 2011, 3-48.
61. Park E.J., Yi J., Chung K.H., Ryu D.Y., Choi J., Park K. Oxidative stress and apoptosis induced by titanium dioxide nanoparticles in cultured BEAS-2B cells. Toxicol. Lett. 2008, 180:222-229.
62. Rengasamy A., Kommineni C., Jones J.A., Fedan J.S. Effects of hard metal on nitric oxide pathways and airway reactivity to methacholine in rat lungs. Toxicol. Appl. Pharmacol. 1999, 157:178-191.
63. Rivolta G., Nicoli E., Ferretti G., Tomasini M. Hard metal lung disorders: analysis of a group of exposed workers. Sci. Total Environ. 1994, 150:161-165.
64. Rizzato G., Fraioli P., Sabbioni E., Pietra R., Barberis M. Multi-element follow up in biological specimens of hard metal pneumoconiosis. Sarcoidosis 1992, 9:104-117.
65. Roesems G., Hoet P.H., Dinsdale D., Demedts M., Nemery B. In vitro cytotoxicity of various forms of cobalt for rat alveolar macrophages and type II pneumocytes. Toxicol. Appl. Pharmacol. 2000, 162:2-9.
66. Ruokonen E.L., Linnainmaa M., Seuri M., Juhakoski P., Soderstrom K.O. A fatal case of hard-metal disease. Scand. J. Work Environ. Health 1996, 22:62-65.
67. Schutze S., Machleidt T., Adam D., Schwandner R., Wiegmann K., Kruse M.L., Heinrich M., Wickel M., Kronke M. Inhibition of receptor internalization by monodansylcadaverine selectively blocks p55 tumor necrosis factor receptor death domain signaling. J. Biol. Chem. 1999, 274:10203-10212.
68. Shivapurkar N., Reddy J., Chaudhary P.M., Gazdar A.F. Apoptosis and lung cancer: a review. J. Cell. Biochem. 2003, 88:885-898.
69. Simeonova P.P., Erdely A. Engineered nanoparticle respiratory exposure and potential risks for cardiovascular toxicity: predictive tests and biomarkers. Inhal. Toxicol. 2009, 21(Suppl. 1):68-73.
70. Song Y., Li X., Du X. Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma. Eur. Respir. J. 2009, 34:559-567.
71. Stearns R.C., Paulauskis J.D., Godleski J.J. Endocytosis of ultrafine particles by A549 cells. Am. J. Respir. Cell Mol. Biol. 2001, 24:108-115.
72. Stefaniak A.B., Day G.A., Harvey C.J., Leonard S.S., Schwegler-Berry D.E., Chipera S.J., Sahakian N.M., Chisholm W.P. Characteristics of dusts encountered during the production of cemented tungsten carbides. Ind. Health 2007, 45:793-803.
73. Stefaniak A.B., Virji M.A., Day G.A. Characterization of exposures among cemented tungsten carbide workers. Part I: Size-fractionated exposures to airborne cobalt and tungsten particles. J. Expo. Sci. Environ. Epidemiol. 2009, 19:475-491.
74. Stieber P., Holdenrieder S. Lung cancer biomarkers - Where we are and what we need. Cancer Biomark. 2010, 6:221-224.
75. Sun L., Li Y., Liu X., Jin M., Zhang L., Du Z., Guo C., Huang P., Sun Z. Cytotoxicity and mitochondrial damage caused by silica nanoparticles. Toxicol. In Vitro 2011, 25:1619-1629.
76. Trautmann H. Pneumoconiosis due to inhaltion of hard metal dusts. Hefte Unfallheilkd. 1958, 56:99-103.
77. Val S., Hussain S., Boland S., Hamel R., Baeza-Squiban A., Marano F. Carbon black and titanium dioxide nanoparticles induce pro-inflammatory responses in bronchial epithelial cells: need for multiparametric evaluation due to adsorption artifacts. Inhal. Toxicol. 2009, 21(Suppl. 1):115-122.
78. Wang X.F., Ding B., Li B.Y. Biomimetic electrospun nanofibrous structures for tissue engineering. Mater. Today 2013, 16:229-241.
79. Wilhelmi V., Fischer U., van Berlo D., Schulze-Osthoff K., Schins R.P., Albrecht C. Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: facts and artefacts. Toxicol. In Vitro 2012, 26:323-334.
80. Wu Y.-L., Putcha N., Ng K.W., Tai Leong D., Lim C.T., Loo S.C.J., Chen X. Biophysical Responses upon the Interaction of Nanomaterials with Cellular Interfaces. Acc. Chem. Res. 2012, 46:782-791.
81. Yao Z., Stiglich J., Sudarshan T. Nanosized WC-Co holds promise for the future. Metal Powder Rep. 1998, 53:26-33.
82. Zhang L.W., Monteiro-Riviere N.A. Mechanisms of quantum dot nanoparticle cellular uptake. Toxicol. Sci. 2009, 110:138-155.
83. Zhang X.D., Zhao J., Bowman L., Shi X., Castranova V., Ding M. Tungsten carbide-cobalt particles activate Nrf2 and its downstream target genes in JB6 cells possibly by ROS generation. J. Environ. Pathol. Toxicol. Oncol. 2010, 29:31-40.
84. Zhao J., Castranova V. Toxicology of nanomaterials used in nanomedicine. J. Toxicol. Environ. Health B Crit. Rev. 2011, 14:593-632.